John R Gentsch

Title: John R Gentsch: Innovator in Rotavirus Research

Introduction

John R Gentsch is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of virology, particularly in the study of rotaviruses. His work has implications for public health, especially in the development of vaccines and immunization protocols.

Latest Patents

John R Gentsch holds a patent for the rotavirus strain G9P11. This patent includes an isolated rotavirus of the strain G9P11, an isolated nucleic acid encoding the rotavirus, and a purified antigen specific for the rotavirus. Additionally, it provides an isolated nucleic acid that selectively hybridizes under high stringency conditions with the nucleic acid encoding the virus. The patent also describes a purified antibody that selectively binds the virus of strain G9P11, as well as the G9P11 rotavirus in a pharmaceutically acceptable carrier for administration in an immunization protocol. Furthermore, it includes variations of the G9P11 rotavirus, wherein the G9 and P11 genes are substituted.

Career Highlights

John R Gentsch is associated with the United States of America as represented by the Department of Health. His work has been pivotal in advancing the understanding of rotavirus and its implications for vaccine development. He has been recognized for his innovative approaches to tackling viral infections.

Collaborations

John has collaborated with notable colleagues such as Bimal K Das and Roger I Glass. Their combined expertise has contributed to significant advancements in rotavirus research and public health initiatives.

Conclusion

John R Gentsch's contributions to rotavirus research exemplify the importance of innovation in the field of virology. His patent for the G9P11 strain is a testament to his dedication to improving public health through scientific research.